EGFR and non-small cell lung carcinoma: Exon 20 insertions were among the earliest EGFR mutations identified in NSCLC alongside exon 19 deletions and L858R mutations.23,24 However, reports regarding the incidence and clinical outcome of NSCLC patients with these insertions were initially limited.